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Abstract

Purpose: The objective of this research project was to identify proteins secreted from human lacrimal fluids
onto the extra-ocular surface of the eye that could be later used to predict eye health, disease, and age-related
changes. The identification of specific lacrimal proteins in relative quantities and patterns in younger versus
older patients may reflect both ocular and extra-ocular disease states.
Methods: This observational study collected samples of lacrimal fluid from 20 subjects between the ages of 18
and 25 years and 20 subjects over the age of 50 years with the use of Schirmer strips. The protein composition
of these lacrimal fluid samples was then analyzed to determine specific proteins that evidenced unique
patterns among the subject populations.
Results: The protein concentrations between the two age groups (n = 40) was significantly higher in the
younger patient group (1408.3 ug/mL versus 1152.5 ug/mL, p = 0.03). No consistent qualitative differences
in the protein bands were observed between the two different patient age groups. However, excising and
analyzing the outlying protein bands revealed unique proteins within the older patient group (aldehyde
dehydrogenase and serotransferrin precursor). Preliminary attempts were made to determine the presence of
proteins in lacrimal fluid that may originate from cells lining the ducts and blood vessels associated with the
ocular environment.
Conclusion: These preliminary results in age related differences in eye lacrimal fluid will contribute to future
research endeavors in order to determine which specific proteins were increased or decreased quantitatively in
the younger population, if any, and what role they might have in eye health, disease, and age-related changes.
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Abstract
Purpose: The objective of this research project was to identify proteins secreted from human lacrimal fluids onto the
extra-ocular surface of the eye that could be later used to predict eye health, disease, and age-related changes. The
identification of specific lacrimal proteins in relative quantities and patterns in younger versus older patients may reflect
both ocular and extra-ocular disease states.
Methods: This observational study collected samples of lacrimal fluid from 20 subjects between the ages of 18 and 25
years and 20 subjects over the age of 50 years with the use of Schirmer strips. The protein composition of these lacrimal
fluid samples was then analyzed to determine specific proteins that evidenced unique patterns among the subject
populations.
Results: The protein concentrations between the two age groups (n = 40) were significantly higher in the younger patient
group (1408.3 ug/mL versus 1152.5 ug/mL, p = 0.03). No consistent qualitative differences in the protein bands were
observed between the two different patient age groups. However, excising and analyzing the outlying protein bands
revealed unique proteins within the older patient group (aldehyde dehydrogenase and serotransferrin precursor).
Preliminary attempts were made to determine the presence of proteins in lacrimal fluid that may originate from cells
lining the ducts and blood vessels associated with the ocular environment.
Conclusion: These preliminary results in age related differences in eye lacrimal fluid will contribute to future research
endeavors in order to determine which specific proteins were increased or decreased quantitatively in the younger
population, if any, and what role they might have in eye health, disease, and age-related changes.
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Introduction
The eye is an ocular organ capable of
distinguishing between various shapes and colors in
order to produce an elaborate vision field for humans. It
is considered to be one of the most complex organs
within the human body. It is often cited as an example of
a supposed irreducible complexity due to its intricate
anatomical parts, all of which are dependent upon each
other for appropriate functionality.1
An often-overlooked feature of the eye that truly
contributes to its complex functionality is its
surrounding lacrimal fluid.2 This extracellular fluid is
secreted by the acinar and ductal cells of the lacrimal
gland, located in the upper temporal part of the orbit
within the lacrimal fossa.2,3 The secreted lacrimal fluid
consists of water, electrolytes (sodium, potassium,
calcium, magnesium, chloride, phosphate, and
bicarbonate, etc.), protein (enzymes, growth factors,
cytokines), and other small molecule metabolites (amino
acids, urea, glucose, lactate, etc.), which serve to
lubricate the ocular surface, provide oxygen to the
avascular cornea and inhibit bacterial growth.2,4,5
Additionally, without this fluid, light would not be
appropriately refracted onto the retina.2,4
Lacrimal fluid comprises the aqueous
component of the eye’s tear film, which is classified into
three main layers: the outer lipid layer, middle aqueous
layer, and inner mucin layer.2,6 The lipid layer’s primary
source is the Meibomian glands, which produce both
non-polar and polar lipids dispersed with various
proteins serving to stabilize the tear film.2,6 The mucin
layer’s primary source is the goblet cell, and serves as a
border between the tear film and the ocular surface.2,6 It
has been demonstrated that the total protein
concentration of normal lacrimal fluid within healthy
individuals ranges anywhere from 6 to 11 mg/ml and
contains anywhere from 500 to 1500 different proteins,
of which 10 to 15 percent are considered to be
extracellularly derived.6
These proteins present within lacrimal fluid not
only function to protect and nourish the eye, but may
also serve as biomarkers to indicate the presence or
absence of an underlying pathology.6 The variations in
tear compositions have been shown to correlate with
both ocular and extra-ocular conditions.6 Therefore, they
are an ideal source for the identification of biomarkers
that may indicate the presence or absence of disease, and
have the potential to offer greater insight into the
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underlying pathology of different disease states.6 By
identifying specific lacrimal proteins in relative
quantities, their close relationship to both ocular and
extra-ocular disease states may be better understood.
A total of 1543 lacrimal fluid proteins were
recently discovered and developed into a reference list.7
Lysozyme, lactoferrin, sIgA, and GIIA phospholipase
(PLA2) are only several of the important tear proteins
that offer defense against pathogens through broadspectrum antimicrobial activity.6 Calgranulin A (S100
A8), an inflammatory-related protein, has been revealed
to be present in higher quantities in individuals with
keratocojunctivitis sicca.6 Patients with allergic
conjunctivitis were observed to have significant
increases in tear IgE levels, osteopontin (an adhesive
matrix protein), and substance P (a neurotransmitter
involved with neurogenic inflammation).6 Collagenase 2
(MMP-8) and gelatinase B (MMP-9) were both
increased in people with ocular rosacea, a chronic
inflammatory disease affecting the eye.6 Additionally,
treatment with oral doxycycline in these individuals was
shown to decrease levels of MMP-9 from a mechanism
independent of its antimicrobial activity.6
Among the extra-ocular disease states that have
been linked to an increase in lacrimal proteins are
diabetes mellitus and various cancers.6 Tear specific prealbumin (TSPA) concentrations were decreased and
lysozyme increased in the tear fluid of diabetics with
pre-proliferative diabetic retinopathy.6 Concentrations of
nerve growth factor (NGF) were increased in the tear
fluid of diabetics with proliferative diabetic retinopathy.6
These findings indicate the potential to identify earlyonset diabetic ocular dysfunction.6 Lacryglobin was
detected in higher concentrations in patients with breast,
lung, colon, and prostate cancers when compared to noncancer patients.6,8 In a study with 50 subjects, roughly 80
to 90 percent of patients with breast and lung cancer and
100 percent of patients with colon and prostate cancer
had detectable levels of lacryglobin in their lacrimal
fluids, relative to the 60 percent of control patients.8
Overall, the variations in tear fluid composition suggest
that proteins and other tear components could become
useful biomarkers of disease presence and severity.
Because the collection technique can drastically
affect the analysis of the tear fluid, a brief discussion of
the advantages and disadvantages between the various
lacrimal fluid collection techniques is warranted.6 The
Schirmer’s strip test and glass capillary tubes are two of
the most popular collection techniques.6,9 The

Excerpts in Pharmacy Research Journal Vol. 1 No. 1 (2015)

Schirmer’s strip test is commonly used in ophthamology
clinics to aid in the diagnosis of dry eye.6,9 It consists of
a strip that is placed inside the conjunctival sac (eyelid)
for roughly five minutes or until the strip is filled with
tear fluid.6,9 Although commonly used, this method can
often cause discomfort and has the tendency to collect
unwanted epithelial proteins from the surface of the
cornea or conjunctiva.6,9 The glass capillary tube method
involves placing the tip of the capillary tube in the lower
tear meniscus to allow for the fluid to be naturally drawn
into the tube.6 Although this technique theoretically
allows for minimal contact, it assumes the person is
experienced with the procedure.6 There is a risk of the
capillary tube touching the ocular surface, especially
with inexperienced individuals.6 Additionally, this
process is generally very slow and is usually not possible
in patients with a low tear fluid volume (dry eye, elderly,
etc.).6
A biomarker is typically defined as any biologic
substance that can be objectively measured to indicate
the presence, absence, or severity of a normal or
pathological process, or a pharmacological response to a
therapeutic intervention.10 Common biomarkers include,
but are not limited to: B-type natriuretic protein (BNP)
for heart failure, troponin for myocardial infarctions,
low-density lipoprotein (LDL) for atherosclerotic
cardiovascular disease, hemoglobin A1c for diabetes,
and prostate specific antigen (PSA) for prostate cancer.
The typical process for a biomarker development
includes its initial discovery, where a potential
biomarker is identified.10 Once identified, the biomarker
can be linked to a normal process, pathological process,
or response to a pharmacological intervention within the
confirmation stage of development.10 If the biomarker is
successfully linked to a specific process, it typically
enters the validation and refinement stage where its
relevance to the population can then be established.10
Lastly, the biomarker is adopted once its clinical utility
has been identified.10
The initial discovery stage of biomarker
development, as its main purpose is to identify potential
biomarkers that can be linked to various processes at a
later time. Our goal was to identify proteins located in
human lacrimal fluids that could be later used to predict
eye health, disease, and age-related changes. The
purpose of the research was to determine the age-related
differences in tear fluid composition between different
age groups. We analyzed human lacrimal fluid from
individuals of varying ages, and subsequently
determined a relationship between the findings and the
2|Page

disease state, eye health, and age-related changes of the
corresponding individuals. By looking at the variation in
proteins within lacrimal fluids of patients in different age
groups we hope to identify any variations that could
potentially link a patient with a particular age group and
possibly, at a later time, a specific disease.
Materials and Methods
Subject Enrollment
Subjects were enrolled in the study using a quota
sampling strategy. A quota of 20 to 25 individuals was
set for the age groups of 18 to 24 years old and over 50
years old. Individuals were conveniently selected from
the Cedarville University School of Pharmacy student
population and a local practicing optometrist’s patient
database. Individuals who have worn contacts within the
past year were excluded from the study. All of the
sample collection and analysis was completed by
professional students of the Cedarville University School
of Pharmacy during the time period of August 2013 to
January 2015, under the instruction and validation of a
faculty advisor and a practicing optometrist. IRB
approval was obtained from the Institutional Review
Board for Human Subjects Research of Cedarville
University.
Sample Collection
Each subject was provided with information
about the study upon their arrival at the Health Sciences
Center of Cedarville University. The subject then
entered the simulation clinic with two researchers and
was asked to sign a consent form. If the subject indicated
his or her willingness to participate in the study, he or
she was assigned a subject number and the data
collection process began. The first component of the
process consisted of a short interview to record any
aspects of the subject’s personal history that could affect
the protein components of his or her lacrimal fluid, such
as age, occurrence of laser eye surgery, use of eye drops,
use of eyeglasses, any current or chronic health problems
they may have, and birth control status. Once the
interview concluded, a researcher collected a sample of
the subject’s lacrimal fluid, one from each eye. While
wearing gloves, the researcher used a Schirmer strip to
collect a 30-50 microliter sample of lacrimal fluid from
the lacrimal lake of the lower eyelid of each eye. The
Schirmer strip was inserted inside the lower eyelid of
each eye and remained there for approximately 2-5
minutes, depending on the time needed for the correct
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amount of sample to be collected. Strips were stored in a
secure minus 80° C freezer until the time of analysis.
Data Analysis
The mass of sample collected with each
Schirmer strip was recorded by taring a scale with a
microfuge tube containing an unused Schirmer strip and
then obtaining the mass of each microfuge tube
containing a patient sample Schirmer strip.
The lacrimal fluid sample was extracted from
each Schirmer strip using 100 microliters/strip of tear
extraction buffer (500mM NaCl, 0.5% tween 20,
phosphate buffered saline, pH 7.4, 1% bovine serum
albumin, protease inhibitors, plus 1 mM NaVO3, 1mM
PMSF, and 1mM benzamidine). Extraction was
performed for 1 hour at 4 °C with end-over-end rotation
and collection of fluid by centrifugation for 5 minutes at
13,500 rpms. A standard BCA protein assay was
utilized to quantitate the protein content of each
sample.11 Polyacrylamide gel electrophoresis was
utilized to separate collected proteins based on charge
and molecular weight.12
Proteins were localized in each gel using the
Pierce® Silver Stain for Mass Spectrometry method.13
This method is compatible with the process of protein
digestion by enzymes to create peptide fragments for
mass spectrometry analysis.13 Gel images were collected
and photographed utilizing an iPad camera application.
Unique protein bands from the gels were excised using a
sterile razor, and each excised band was placed into
individual microfuge tubes. Images of the gels after the
excision of the unique protein bands were obtained to
confirm identity. The images of the gels were also
recorded on a CCD camera with Alpha imager software.
Excised protein bands were processed for
analysis by mass spectrometry by de-staining the bands
with freshly prepared buffers.13 Following the
completion of this protocol, selected excised gel pieces
were sent to the University of Cincinnati Proteomics
Laboratory where the preliminary analyses were
completed utilizing mass spectrometry. Additional
analyses of the tear samples were conducted to
determine the presence of proteins possibly shed from
endothelial cells during normal cell turnover. To
accomplish this secondary objective, we performed a
standard dot blot method to search for the presence of
immobilized proteins on nitrocellose membranes.14
3|Page

Five micrograms of lacrimal tear fluid were
spotted onto the nitrocellulose membrane using a
narrow-mouth pipette tip and dot blot apparatus. Once
the membrane dried sufficiently, the non-specific sites
were blocked by soaking the membrane in 5% BSA in
TBS-T (20 mM Tris-HCl, 150 mM NaCl, pH 7.5, 0.5%
Tween 20) for one hour at room temperature. Each
membrane was incubated with the primary antibody
diluted in BSA/TBS-T (0.1% BSA in TBS-T) for 30
minutes at room temperature. Membranes were washed
three times with TBS-T for 3-5 minutes per wash.
Secondary antibodies conjugated with HRP were added
to the membranes for 30 minutes at room temperature.
Final washes were performed with TBS-T (first wash, 15
minutes; second and third washes, 5 minutes each).
After a final wash with TBS for 5 minutes, membranes
were processed for enhanced chemiluminescence (ECL,
GE Healthcare) for 1 minute before exposing it to the
alpha-imager.
Results
Patient demographics
Patients enrolled in this study were selected
conveniently from the surrounding Cedarville/Xenia,
Ohio area. Students within the Cedarville School of
Pharmacy were selected for the young group and
patients from the Cedarville and Xenia practice sites of
Dr. Florkey were selected for the older patient group. A
total of 40 patients were enrolled in the study (20
patients per age group), and prior to providing samples
patients were asked about their past medical history
regarding: eye health, health concerns, chronic disease
states, menopausal status, other factors that alter
hormone levels, and age. All results were strictly patient
reported. Chronic disease states were more prevalent in
the old group (6 patients from the old group compared to
1 from the young group). The young group had 10 males
and 10 females, whereas the old group had 8 males and
12 females. The average age for the young group was 22
years old, with an average age of 60 years old for the old
group (one patient in the old group did not have an age
recorded). Male average age in the study was 21.7 years
old and 59.8 years old for the young and old groups
respectively. Female average age in the study was 22.2
years old and 60.2 years old for the young and old
groups respectively.
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Lacrimal Fluid

Figure 1A

The young group produced an average larger
volume of lacrimal fluid (LF) than the older group;
0.0314 ± 0.008 g of LF collected from the young group
compared to 0.0263 ± 0.005 g of LF from the old group.
Eyes within the groups produced on average different
volumes of LF. In the young group the right eye
produced a greater volume of LF, 0.0323 ± 0.008 g
compared to 0.0304 ± 0.008 g of LF from the left eye.
Conversely, in the old group the left eye produced, on
average, a greater volume of LF, 0.0272 ± 0.008 g
compared to 0.0253 ± 0.003 g of LF collected from the
right eye.
BCA Protein Assay
Figure 1B
To examine the difference in protein
concentration between groups, as well as between the
left and right eyes, samples were analyzed by a BCA
assay. Which revealed that the young group had a
greater average concentration of protein in LF than the
old group, 1408.33 ± 17.0 µg/mL compared to 1152.46
± 16.3 µg/mL. A paired two-sample t-test revealed a
statistically significant difference between protein
concentrations for each group. In each group, the eye
that produced more volume also had the greatest protein
concentration. The young group averaged a protein
concentration of 1578.91 ± 21.5 µg/mL for the right eye
and 1224.94 ± 21.4 µg/mL for the left eye. The old
group’s protein concentration did not vary as greatly as
the young group. The old group’s left eye averaged a
greater protein concentration (1159.93 ± 31.0 µg/mL)
than the right eye (1144.99 ± 27.2 µg/mL).
Pierce® Silver Stain
In order to find and extract unique proteins from
the samples, all samples were analyzed using the silver
stain method. This analysis allowed the research team to
observe all proteins found in LF that was collected, and
select unique bands for further identification. Figures 1A
and 1B are representative gels showing the migration of
proteins and level of clarity. Initial observations were to
identify bands that were found to be unique and
presented differently from other proteins within the same
gel. Any protein that was unique was excised, destained, and sent for mass spectrometry analysis. For
this study proteins from the left eye of an older patient
were analyzed in more detail.
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A
B
C
D

Figure 1A and 1B. Representative protein gels of
separated lacrimal proteins obtained from human
lacrimal fluid obtained from the left (L) and right (R)
eyes absorbed onto Schirmer Strips. Proteins were
separated on 8% percent PAGE gels at 100 nanograms
per well. Molecular weight markers are indicated in
kilodaltons (BioRad protein plus). Pierce silver stain
protocol was used to stain proteins prior to mass
spectrometry analysis. Figure 1A represents samples
from young patients. Figure 1B represents Older
patients, patient OL2 and OR2 were of interest in the
initial mass spectrometry search. In figure 1B, labels A,
B, C and D represent bands isolated for more detailed
analysis.
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MALDI-TOF/TOF and MASCOT
After bands were excised, they were de-stained
and sent for mass spectrometry in order to be identified.
Theses 4 protein bands (Labeled A-D in figure 1B) were
reduced, alkylated, digested with trypsin and identified
by MALDI-TOF/TOF and a MASCOT search of the
mammalian proteome. The proteins were cleaved into
peptides for peptide identification and potential
proteomic identification. Band A (OL2) was determined
to be made of human serum albumin in a complex with
myristic acid and tri-iodobenzoic acid, and Ig alpha-1
chain (C region). Band B (OL2) had the exact same
identification as Band A. Band C (OL2) contained
aldehyde dehydrogenase, another tentative identification
of the contents (meaning further confirmation would be
required to accurately identify the protein) was IgG1
(Heavy chain H Lambda). Finally, Band D (OL2)
contained serotransferrin precursor and albumin (isoform
CRA_t).
Fibronectin Type lll Repeat in Lacrimal Fluid
All lacrimal fluids from Schirmer strips from
young and older patients were bound to nitrocellulose in
a dot blot format and probed for proteins known to be
associated with endothelial cells, CD31 and fibronectin
type lll repeats. Two patient samples had detectable
levels of fibronectin type lll repeat protein, in Row A
spot A2 and A10 (numbering pictured below each dot
blot). The dot blot was stripped and re-probed with antitubulin antibody as a negative control, results are shown
in figure 3, no detectable reactivity.

Figure 2. Dot blot demonstrating fibronectin type lll
repeat like protein present in extracted tear fluid. Spots
5|Page

A2 and A10 (asterisk) are samples of young patients that
did not wear contacts or have any diagnosis related to an
eye disorder and are positive for reactivity to fibronectin
type lll repeat. Spots C3 and H7 are positive controls,
purified protein from HEK293 cells. D8 is fluid from
tear blink an artificial wetting agent for eyes.

Figure 3. The dot blot used for fibronectin type lll
reactivity was stripped and re-probed with a mouse antitubulin antibody to demonstrate non-reactivity with an
unrelated antibody.
Discussion
The purpose of this study was to identify any
differences in the protein makeup of lacrimal fluid
between young and old patients. The resulting
differences could then be utilized as a baseline for future
studies to identify which specific proteins might
correlate with disease and eye health. Preliminary gel
electrophoresis runs revealed some minor but distinct
variations between young and old patient groups. There
were three unique protein bands located in one particular
patient (Left eye patient 5), and one was from the young
group (Left eye patient 4). After excising the three
outlying protein bands and sending them to be analyzed,
the proteins were identified to be albumin complexed
with myristic acid, albumin isoform CRA, partial
immunoglobulin, aldehyde dehydrogenase, and
serotransferrin precursor. Both albumin with myristic
acid and partial immunoglobulin were found in the
young and old groups. However, aldehyde
dehydrogenase and serotransferrin precursor were
unique to the outlying protein band within the old group.
The presence of aldehyde dehydrogenase and
serotransferrin precursor protein may indicate the
occurrence of age-related changes to the eye. However,
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these proteins were only linked to the left eye of one
specific subject. The subject, in which these proteins
were identified, was a female, 66 years of age, with a
past medical history of osteoporosis. Additionally, her
eyes were dilated 20 minutes prior to a lacrimal sample
being taken. Thus, the presence of aldehyde
dehydrogenase and serotransferrin in the lacrimal sample
could have been due to inflammation from her chronic
osteoporosis or due to the fact that her eyes were dilated
beforehand. Because the dilatory drops get metabolized
very quickly on the ocular surface and should not be
present after roughly 10 minutes, it is not believed that
the dilatory drops themselves had an effect on the
lacrimal fluid composition. However, the dilatory effects
were still present, and could have contributed to an
increase in certain proteins within the subject’s lacrimal
fluid. Because only one elderly subject’s lacrimal fluid
was observed to contain these unique proteins, future
studies would need to be conducted in order to
hypothetically link these proteins to actual ocular agerelated changes or inflammatory disease states and if
dilation in some way affects protein expression
independently of disease status. No other patients in the
study had pupil dilation prior to sample collection.
During the course of the study, the
concentrations of the proteins in the lacrimal fluid were
able to be calculated. When comparing the means, it was
found that the young subjects had a significantly higher
protein concentration within their lacrimal fluid (p=
0.03). Future studies could be aimed at determining what
specific proteins, if any, were increased in younger
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